Last reviewed · How we verify
NCT05250245
Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
Phase 4 trial testing Tolterodine Tartrate 4 MG in Overactive Bladder in 60 participants. Completed in 1 January 2022.
30 December 2021
Quick facts
| Lead sponsor | Yuzuncu Yil University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 June 2020 |
| Primary completion | 30 December 2021 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Tolterodine Tartrate 4 MG
- Continuous positive airway pressure therapy (CPAP)
Conditions studied
- Overactive Bladder — all drugs for Overactive Bladder →
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
- Overactive Bladder Syndrome — all drugs for Overactive Bladder Syndrome →
Sponsor
Yuzuncu Yil University
Who can join
Adults 18 to 60, female only, with Overactive Bladder or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, we aim to determine whether combined tolterodine and CPAP therapy is a more effective treatment for patients with OSAS than CPAP treatment only.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05250245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overactive Bladder
Currently open trials in the same condition.
- NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
- NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
- NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
- NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting
- NCT06935240 — Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity · NA · recruiting
Other Yuzuncu Yil University trials
Trials by the same sponsor.
- NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
- NCT07523399 — Joint Health, Balance and Quality of Life in Adults With Hemophilia A · recruiting
- NCT07416877 — The Effects of Dual-Task Exercises on Parameters After Total Knee Arthroplasty · NA · not yet recruiting
- NCT07243925 — Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patient · NA · active not recruiting
- NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05250245 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuzuncu Yil University
- Last refreshed: 22 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05250245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing